Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets

Diabetes

Volumn 49, Issue 3, 2000, Pages 392-398

  Iismaa, Tiina P ^a   Kerr, Elizabeth A ^a   Wilson, Justine R ^a   Carpenter, Lee ^a   Sims, Natalie ^a   Biden, Trevor J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; COMPLEMENTARY DNA; INSULIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; GENETIC TRANSFECTION; INSULIN RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0034007213     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.3.392     Document Type: Article

References (36)

1. Ahren B, Karlsson S, Lindskog S: Cholinergic regulation of the endocrine pancreas. Prog Brain Res 84:209-218, 1990
2. Stubbe JH, Steffens AB: Neural control of insulin secretion. Horm Metab Res 25:507-512, 1993
3. Conaway HM, Griffey MA, Whitney JE: Characterization of acetylcholine-induced insulin secretion in the isolated perfused dog pancreas. Proc Soc Exp Biol Med 150:308-312, 1975
4. Malaisse WJ, Malaisse-Lagae F, Wright PH, Ashmore J: Effects of adrenergic and cholinergic agents upon insulin secretion in vitro. Endocrinology 80:975-978, 1967
5. Zawalich WS, Zawalich KC, Rasmussen H: Cholinergic agonists prime the β-cell to glucose stimulation. Endocrinology 125:2400-2406, 1989
6. ++ uptake by rat pancreatic islets. Endocrinology 107:924-929, 1980
7. Wollheim CB, Biden TJ: Second messenger function of inositol 1,4,5-trisphosphate: early changes in inositol phosphates, cytosolic Ca2+, and insulin release in carbamylcholine-stimulated RINm5F cells. J Biol Chem 261:8314-8319, 1986
8. Biden TJ, Davison AGM, Prugue M: Regulation by membrane potential of phosphatidylinositol hydrolysis in pancreatic islets. J Biol Chem 268:11065-11072, 1993
9. Gagerman E, Idahl L-A, Meissner HP, Tahljedal I-B: Insulin release, cGMP, cAMP, and membrane potential in acetylcholine-stimulated islets. Am J Physiol 235:E493-E500, 1978
10. Morgan NG, Rumford GM, Montague W: Studies on the role of inositol triphosphate in the regulation of insulin secretion from isolated islets of Langerhans. Biochem J 228:713-718, 1985
11. Bonner TI: New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci 10:11-15, 1989
12. Dunlop ME, Larkins RG: Muscarinic-agonist and guanine nucleotide activation of polyphosphoinositide phosphodiesterase in isolated islet-cell membranes. Biochem J 240:731-737, 1986
13. Wollheim CB, Biden TJ: Signal transduction in insulin secretion: comparison between fuel stimuli and receptor agonists. Ann N Y Acad Sci 488:317-333, 1986
14. Henquin JC, Nenquin M: The muscarinic receptor subtype in mouse pancreatic B-cells. FEBS Lett 236:88-92, 1988
15. Santos RM, Rojas E: Muscarinic receptor modulation of glucose-induced electrical activity in mouse pancreatic B-cells. FEBS Lett 249:411-417, 1989
16. Verspohl EJ, Tacke R, Mutschler E, Lambrecht G: Muscarinic receptor subtypes in rat pancreatic islets: binding and functional studies. Eur J Pharmacol 178:303-311, 1990
17. Boschero AC, Szpak-Glasman M, Carneiro EM, Bordin S, Paul I, Rojas E, Atwater I: Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors. Am J Physiol 268:E336-E342, 1995
18. Tang SH, Sharp GWG: Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing. Diabetes 46:1419-1423, 1997
19. Biden TJ, Prugue ML, Davison AGM: Evidence for phosphatidyl-inositol hydrolysis in islets stimulated with carbamoylcholine: kinetic analysis of inositol polyphosphate metabolism. Biochem J 285:541-549, 1992
20. Easom RA, Landt M, Colca JR, Hughes JH, Turk J, McDaniel M: Effects of secretagogues on protein kinase C-catalysed phosphorylation of an endogenous substrate in isolated pancreatic islets. J Biol Chem 265:14938-14946, 1990
21. Jones PM, Persaud SJ, Howell SL: Protein kinase C and the regulation of insulin secretion from pancreatic B cells. J Mol Endocrinol 6:121-127, 1990
22. Henquin JC, Garcia MC, Bozem M, Hermans MP, Nenquin M: Muscarinic control of pancreatic B cell function involves sodium-dependent depolarization and calcium influx. Endocrinology 122:2134-2142, 1988
23. Gilon P, Henquin JC: Activation of muscarinic receptors increases the concentration of free Na+ in mouse pancreatic B-cells. FEBS Lett 315:353-356, 1993
24. Sanchez-Andres JV, Ripoll C, Soria B: Evidence that muscarinic potentiation of insulin release is initiated by an early transient calcium entry. FEBS Lett 231:143-147
25. 2+ in the electrically excitable pancreatic B-cell. Biochem J 311:259-267, 1995
26. 2+ origin. J Physiol 488:13-24, 1995
27. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
28. Sims NA, White CP, Sunn KL, Thomas GP, Drummond ML, Morrison NA, Eisman JA, Gardiner EM: Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo. Mol Endocrinol 11:1695-1708, 1997
29. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ: Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic receptors. EMBO J 6:3923-3929, 1987
30. Braun T, Schofield PR, Shivers BD, Pritchett DB, Seeburg PH. A novel subtype of muscarinic receptor identified by homology screening. Biochem Biophys Res Commun 149:125-132, 1987
31. Haylett DG: Direct measurement of drug binding to receptors. In Textbook of Receptor Pharmacology. Foreman JC, Johansen T, Eds. Boca Raton, FL, CRC Press, 1996, p. 121-149
32. Ludlam WH, Zang Z, McCarson KE, Krause JE, Spray DC, Kessler JA: mRNAs encoding muscarinic and substance P receptors in cultured sympathetic neurons are differentially regulated by LIF or CNTF. Dev Biol 164:528-539, 1994
33. Van der Zee EA, Buwalda B, Strubbe JH, Strosberg AD, Luiten PGM: Immunocytochemical localization of muscarinic acetylcholine receptors in the rat endocrine pancreas. Cell Tissue Res 269:99-106, 1992
34. Buckley NJ, Bonner TI, Buckley CM, Brann MR: Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35:469-476, 1989
35. Wang SZ, el-Fakahany EE: Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists. J Pharmocol Exp Ther-266:237-243, 1993
36. Richards MH, van Giersbergen PLM: Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists. Br J Pharmacol 114:1241-1249, 1995